Fundies. English
Segment disclosures
Company overviewGE HEALTHCARE TECHNOLOGIES INC.
Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.
Revenue · Reported segment facts
59 dimension combinations 395 retained observations 21 reported periods
Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.
Operating Segments · AIS Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=gehc:AISSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 3771000000 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 7410000000 | USD | 20260729 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 3493000000 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 6872000000 | USD | 20260729 | Open filing evidence |
Operating Segments · AVS Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=gehc:AVSSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 1341000000 | USD | 20260429 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 5354000000 | USD | 20260204 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 1301000000 | USD | 20251029 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 3829000000 | USD | 20251029 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 1289000000 | USD | 20250730 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 2529000000 | USD | 20250730 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 1239000000 | USD | 20260429 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 5131000000 | USD | 20260204 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 1216000000 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 3692000000 | USD | 20251029 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 1249000000 | USD | 20250730 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 2475000000 | USD | 20250730 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 1227000000 | USD | 20250430 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 5094000000 | USD | 20260204 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 1214000000 | USD | 20241030 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 3712000000 | USD | 20241030 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 5012000000 | USD | 20250213 | Open filing evidence |
Operating Segments · AVS Segment · Procedural Guidance Subsegment
Consolidation Items · Statement Business Segments · Subsegments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=gehc:AVSSegmentMember;us-gaap:SubsegmentsAxis=gehc:ProceduralGuidanceSubsegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-03-31 | 641000000 | USD | 20250430 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 2711000000 | USD | 20250213 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 647000000 | USD | 20241030 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 1967000000 | USD | 20241030 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 651000000 | USD | 20250430 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 2666000000 | USD | 20250213 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 641000000 | USD | 20241030 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 1938000000 | USD | 20241030 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 2327000000 | USD | 20250213 | Open filing evidence |
Operating Segments · AVS Segment · Specialized Ultrasound Subsegment
Consolidation Items · Statement Business Segments · Subsegments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=gehc:AVSSegmentMember;us-gaap:SubsegmentsAxis=gehc:SpecializedUltrasoundSubsegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-03-31 | 598000000 | USD | 20250430 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 2420000000 | USD | 20250213 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 569000000 | USD | 20241030 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 1725000000 | USD | 20241030 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 576000000 | USD | 20250430 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 2428000000 | USD | 20250213 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 573000000 | USD | 20241030 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 1774000000 | USD | 20241030 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 2685000000 | USD | 20250213 | Open filing evidence |
Operating Segments · Imaging
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=gehc:ImagingMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 9985000000 | USD | 20230425 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 9433000000 | USD | 20230425 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 8959000000 | USD | 20230425 | Open filing evidence |
Operating Segments · Imaging · Interventional Guidance
Consolidation Items · Statement Business Segments · Subsegments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=gehc:ImagingMember;us-gaap:SubsegmentsAxis=gehc:InterventionalGuidanceMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 1590000000 | USD | 20230425 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 1414000000 | USD | 20230425 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 1333000000 | USD | 20230425 | Open filing evidence |
Operating Segments · Imaging · Radiology
Consolidation Items · Statement Business Segments · Subsegments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=gehc:ImagingMember;us-gaap:SubsegmentsAxis=gehc:RadiologyMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 8395000000 | USD | 20230425 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 8019000000 | USD | 20230425 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 7626000000 | USD | 20230425 | Open filing evidence |
Operating Segments · Imaging Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=gehc:ImagingSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 2299000000 | USD | 20260429 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 9245000000 | USD | 20260204 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 2349000000 | USD | 20251029 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 6693000000 | USD | 20251029 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 2204000000 | USD | 20250730 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 4344000000 | USD | 20250730 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 2140000000 | USD | 20260429 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 8855000000 | USD | 20260204 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 2229000000 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 6462000000 | USD | 20251029 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 2171000000 Restated | USD | 20250730 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 4233000000 Restated | USD | 20250730 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 2062000000 Restated | USD | 20250430 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 8944000000 | USD | 20260204 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 2236000000 Restated | USD | 20241030 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 6552000000 Restated | USD | 20241030 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 2620000000 | USD | 20240731 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 5116000000 | USD | 20240731 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 2496000000 | USD | 20240430 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 8395000000 | USD | 20250213 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 2516000000 | USD | 20231031 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 7276000000 | USD | 20231031 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 2449000000 | USD | 20230725 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 4760000000 | USD | 20230725 | Open filing evidence |
Operating Segments · Imaging Segment · Interventional Guidance
Consolidation Items · Statement Business Segments · Subsegments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=gehc:ImagingSegmentMember;us-gaap:SubsegmentsAxis=gehc:InterventionalGuidanceMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-04-01 – 2024-06-30 | 425000000 | USD | 20240731 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 829000000 | USD | 20240731 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 393000000 | USD | 20240731 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 801000000 | USD | 20240731 | Open filing evidence |
Operating Segments · Others
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=gehc:OthersMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 60000000 | USD | 20230425 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 47000000 | USD | 20230425 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 47000000 | USD | 20230425 | Open filing evidence |
Operating Segments · Pcs
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=gehc:PcsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 2916000000 | USD | 20230425 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 2915000000 | USD | 20230425 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 3675000000 | USD | 20230425 | Open filing evidence |
Operating Segments · Pcs · Life Support Solutions
Consolidation Items · Statement Business Segments · Subsegments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=gehc:PcsMember;us-gaap:SubsegmentsAxis=gehc:LifeSupportSolutionsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 824000000 | USD | 20230425 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 796000000 | USD | 20230425 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 1432000000 | USD | 20230425 | Open filing evidence |
Operating Segments · Pcs · Monitoring Solutions
Consolidation Items · Statement Business Segments · Subsegments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=gehc:PcsMember;us-gaap:SubsegmentsAxis=gehc:MonitoringSolutionsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 2092000000 | USD | 20230425 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 2119000000 | USD | 20230425 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 2243000000 | USD | 20230425 | Open filing evidence |
Operating Segments · PCS Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=gehc:PCSSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 675000000 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 1379000000 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 704000000 | USD | 20260429 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 3086000000 | USD | 20260204 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 731000000 | USD | 20251029 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 2262000000 | USD | 20251029 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 778000000 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 1531000000 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 753000000 | USD | 20260429 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 3125000000 | USD | 20260204 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 779000000 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 2298000000 | USD | 20251029 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 772000000 | USD | 20250730 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 1519000000 | USD | 20250730 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 747000000 | USD | 20250430 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 3142000000 | USD | 20260204 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 764000000 | USD | 20241030 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 2315000000 | USD | 20241030 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 770000000 | USD | 20230725 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 1551000000 | USD | 20230725 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 781000000 | USD | 20240430 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 2916000000 | USD | 20250213 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 701000000 | USD | 20231031 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 2130000000 | USD | 20231031 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 713000000 | USD | 20230725 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 1429000000 | USD | 20230725 | Open filing evidence |
Operating Segments · PCS Segment · Life Support Solutions Subsegment
Consolidation Items · Statement Business Segments · Subsegments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=gehc:PCSSegmentMember;us-gaap:SubsegmentsAxis=gehc:LifeSupportSolutionsSubsegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-03-31 | 197000000 | USD | 20250430 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 931000000 | USD | 20250213 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 223000000 | USD | 20241030 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 677000000 | USD | 20241030 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 220000000 | USD | 20250430 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 859000000 | USD | 20250213 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 191000000 | USD | 20241030 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 627000000 | USD | 20241030 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 824000000 | USD | 20250213 | Open filing evidence |
Operating Segments · PCS Segment · Monitoring Solutions
Consolidation Items · Statement Business Segments · Subsegments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=gehc:PCSSegmentMember;us-gaap:SubsegmentsAxis=gehc:MonitoringSolutionsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-07-01 – 2023-09-30 | 573000000 | USD | 20231031 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 1688000000 | USD | 20231031 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 563000000 | USD | 20230725 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 1115000000 | USD | 20230725 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 506000000 | USD | 20231031 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 1539000000 | USD | 20231031 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 512000000 | USD | 20230725 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 1033000000 | USD | 20230725 | Open filing evidence |
Operating Segments · PCS Segment · Monitoring Solutions Subsegment
Consolidation Items · Statement Business Segments · Subsegments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=gehc:PCSSegmentMember;us-gaap:SubsegmentsAxis=gehc:MonitoringSolutionsSubsegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-03-31 | 556000000 | USD | 20250430 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 2194000000 | USD | 20250213 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 556000000 | USD | 20241030 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 1621000000 | USD | 20241030 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 527000000 | USD | 20250430 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 2283000000 | USD | 20250213 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 573000000 | USD | 20241030 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 1688000000 | USD | 20241030 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 2092000000 | USD | 20250213 | Open filing evidence |
Operating Segments · Pdx
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=gehc:PdxMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 1958000000 | USD | 20230425 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 2018000000 | USD | 20230425 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 1780000000 | USD | 20230425 | Open filing evidence |
Operating Segments · P Dx Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=gehc:PDxSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 843000000 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 1612000000 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 770000000 | USD | 20260429 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 2900000000 | USD | 20260204 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 749000000 | USD | 20251029 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 2110000000 | USD | 20251029 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 729000000 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 1362000000 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 632000000 | USD | 20260429 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 2508000000 | USD | 20260204 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 625000000 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 1862000000 | USD | 20251029 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 639000000 | USD | 20250730 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 1238000000 | USD | 20250730 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 599000000 | USD | 20250430 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 2306000000 | USD | 20260204 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 589000000 | USD | 20241030 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 1715000000 | USD | 20241030 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 568000000 | USD | 20230725 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 1126000000 | USD | 20230725 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 558000000 | USD | 20240430 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 1958000000 | USD | 20250213 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 522000000 | USD | 20231031 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 1485000000 | USD | 20231031 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 478000000 | USD | 20230725 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 962000000 | USD | 20230725 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 484000000 | USD | 20230425 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 2018000000 | USD | 20240206 | Open filing evidence |
Operating Segments · Ultrasound
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=gehc:UltrasoundMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 3422000000 | USD | 20230425 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 3172000000 | USD | 20230425 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 2703000000 | USD | 20230425 | Open filing evidence |
Operating Segments · Ultrasound Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=gehc:UltrasoundSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-03-31 | 824000000 | USD | 20240430 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 815000000 | USD | 20231031 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 2513000000 | USD | 20231031 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 839000000 | USD | 20230725 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 1698000000 | USD | 20230725 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 859000000 | USD | 20240430 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 823000000 | USD | 20231031 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 2466000000 | USD | 20231031 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 828000000 | USD | 20230725 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 1643000000 | USD | 20230725 | Open filing evidence |
Operating Segments · Interventional Guidance · Imaging Segment
Consolidation Items · Subsegments · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:SubsegmentsAxis=gehc:InterventionalGuidanceMember;us-gaap:StatementBusinessSegmentsAxis=gehc:ImagingSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-03-31 | 403000000 | USD | 20240430 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 393000000 | USD | 20230725 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 801000000 | USD | 20230725 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 408000000 | USD | 20240430 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 385000000 | USD | 20230725 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 778000000 | USD | 20230725 | Open filing evidence |
Operating Segments · Life Support Solutions · PCS Segment
Consolidation Items · Subsegments · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:SubsegmentsAxis=gehc:LifeSupportSolutionsMember;us-gaap:StatementBusinessSegmentsAxis=gehc:PCSSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-03-31 | 220000000 | USD | 20240430 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 191000000 | USD | 20231031 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 627000000 | USD | 20231031 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 207000000 | USD | 20230725 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 436000000 | USD | 20230725 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 229000000 | USD | 20240430 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 195000000 | USD | 20231031 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 591000000 | USD | 20231031 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 201000000 | USD | 20230725 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 396000000 | USD | 20230725 | Open filing evidence |
Operating Segments · Life Support Solutions Subsegment · PCS Segment
Consolidation Items · Subsegments · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:SubsegmentsAxis=gehc:LifeSupportSolutionsSubsegmentMember;us-gaap:StatementBusinessSegmentsAxis=gehc:PCSSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 185000000 | USD | 20260429 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 831000000 | USD | 20260204 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 187000000 | USD | 20251029 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 583000000 | USD | 20251029 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 200000000 | USD | 20250730 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 397000000 | USD | 20250730 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 197000000 | USD | 20260429 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 931000000 | USD | 20260204 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 223000000 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 677000000 | USD | 20251029 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 235000000 | USD | 20250730 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 454000000 | USD | 20250730 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 859000000 | USD | 20260204 | Open filing evidence |
Operating Segments · Monitoring Solutions · PCS Segment
Consolidation Items · Subsegments · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:SubsegmentsAxis=gehc:MonitoringSolutionsMember;us-gaap:StatementBusinessSegmentsAxis=gehc:PCSSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-03-31 | 527000000 | USD | 20240430 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 552000000 | USD | 20240430 | Open filing evidence |
Operating Segments · Monitoring Solutions Subsegment · PCS Segment
Consolidation Items · Subsegments · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:SubsegmentsAxis=gehc:MonitoringSolutionsSubsegmentMember;us-gaap:StatementBusinessSegmentsAxis=gehc:PCSSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 519000000 | USD | 20260429 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 2256000000 | USD | 20260204 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 544000000 | USD | 20251029 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 1678000000 | USD | 20251029 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 578000000 | USD | 20250730 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 1135000000 | USD | 20250730 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 556000000 | USD | 20260429 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 2194000000 | USD | 20260204 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 556000000 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 1621000000 | USD | 20251029 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 538000000 | USD | 20250730 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 1065000000 | USD | 20250730 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 2283000000 | USD | 20260204 | Open filing evidence |
Operating Segments · Procedural Guidance Subsegment · AVS Segment
Consolidation Items · Subsegments · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:SubsegmentsAxis=gehc:ProceduralGuidanceSubsegmentMember;us-gaap:StatementBusinessSegmentsAxis=gehc:AVSSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 719000000 | USD | 20260429 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 2752000000 | USD | 20260204 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 662000000 | USD | 20251029 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 1963000000 | USD | 20251029 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 660000000 | USD | 20250730 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 1301000000 | USD | 20250730 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 641000000 | USD | 20260429 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 2711000000 | USD | 20260204 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 647000000 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 1967000000 | USD | 20251029 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 668000000 | USD | 20250730 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 1319000000 | USD | 20250730 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 2666000000 | USD | 20260204 | Open filing evidence |
Operating Segments · Radiology · Imaging Segment
Consolidation Items · Subsegments · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:SubsegmentsAxis=gehc:RadiologyMember;us-gaap:StatementBusinessSegmentsAxis=gehc:ImagingSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-04-01 – 2024-06-30 | 2171000000 | USD | 20240731 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 4233000000 | USD | 20240731 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 2062000000 | USD | 20240430 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 2227000000 | USD | 20240731 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 4315000000 | USD | 20240731 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 2088000000 | USD | 20240430 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 2064000000 | USD | 20230725 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 3982000000 | USD | 20230725 | Open filing evidence |
Operating Segments · Specialized Ultrasound Subsegment · AVS Segment
Consolidation Items · Subsegments · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:SubsegmentsAxis=gehc:SpecializedUltrasoundSubsegmentMember;us-gaap:StatementBusinessSegmentsAxis=gehc:AVSSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 622000000 | USD | 20260429 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 2601000000 | USD | 20260204 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 638000000 | USD | 20251029 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 1866000000 | USD | 20251029 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 630000000 | USD | 20250730 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 1228000000 | USD | 20250730 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 598000000 | USD | 20260429 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 2420000000 | USD | 20260204 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 569000000 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 1725000000 | USD | 20251029 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 581000000 | USD | 20250730 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 1156000000 | USD | 20250730 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 2428000000 | USD | 20260204 | Open filing evidence |
AIS Segment · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=gehc:AISSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 3873000000 | USD | 2026-10-28 · 10:26:29.000Z | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 11284000000 | USD | 2026-10-28 · 10:26:29.000Z | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 3649000000 | USD | 2026-10-28 · 10:26:29.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 10522000000 | USD | 2026-10-28 · 10:26:29.000Z | Open filing evidence |
AIS Segment · Procedural Guidance Subsegment · Operating Segments
Statement Business Segments · Subsegments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=gehc:AISSegmentMember;us-gaap:SubsegmentsAxis=gehc:ProceduralGuidanceSubsegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 772000000 | USD | 2026-10-28 · 10:26:29.000Z | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 2206000000 | USD | 2026-10-28 · 10:26:29.000Z | Open filing evidence |
| 2026-04-01 – 2026-06-30 | 715000000 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 1434000000 | USD | 20260729 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 662000000 | USD | 2026-10-28 · 10:26:29.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 1963000000 | USD | 2026-10-28 · 10:26:29.000Z | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 660000000 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 1301000000 | USD | 20260729 | Open filing evidence |
AIS Segment · Radiology Subsegment · Operating Segments
Statement Business Segments · Subsegments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=gehc:AISSegmentMember;us-gaap:SubsegmentsAxis=gehc:RadiologySubsegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 2463000000 | USD | 2026-10-28 · 10:26:29.000Z | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 7150000000 | USD | 2026-10-28 · 10:26:29.000Z | Open filing evidence |
| 2026-04-01 – 2026-06-30 | 2388000000 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 4686000000 | USD | 20260729 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 2349000000 | USD | 2026-10-28 · 10:26:29.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 6693000000 | USD | 2026-10-28 · 10:26:29.000Z | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 2204000000 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 4344000000 | USD | 20260729 | Open filing evidence |
AIS Segment · Specialized Ultrasound Subsegment · Operating Segments
Statement Business Segments · Subsegments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=gehc:AISSegmentMember;us-gaap:SubsegmentsAxis=gehc:SpecializedUltrasoundSubsegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 639000000 | USD | 2026-10-28 · 10:26:29.000Z | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 1929000000 | USD | 2026-10-28 · 10:26:29.000Z | Open filing evidence |
| 2026-04-01 – 2026-06-30 | 668000000 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 1290000000 | USD | 20260729 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 638000000 | USD | 2026-10-28 · 10:26:29.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 1866000000 | USD | 2026-10-28 · 10:26:29.000Z | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 630000000 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 1228000000 | USD | 20260729 | Open filing evidence |
Imaging
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=gehc:ImagingMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-03-31 | 2496000000 | USD | 20230425 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 2311000000 | USD | 20230425 | Open filing evidence |
Imaging Segment · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=gehc:ImagingSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-12-31 | 10581000000 | USD | 20240206 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 2496000000 | USD | 20230425 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 9985000000 | USD | 20240206 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 2311000000 | USD | 20230425 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 9433000000 | USD | 20240206 | Open filing evidence |
Imaging Segment · Operating Segments · Interventional Guidance
Statement Business Segments · Consolidation Items · Subsegments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=gehc:ImagingSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:SubsegmentsAxis=gehc:InterventionalGuidanceMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-12-31 | 1637000000 | USD | 20240206 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 1590000000 | USD | 20240206 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 1414000000 | USD | 20240206 | Open filing evidence |
Imaging Segment · Operating Segments · Radiology
Statement Business Segments · Consolidation Items · Subsegments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=gehc:ImagingSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:SubsegmentsAxis=gehc:RadiologyMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-12-31 | 8944000000 | USD | 20240206 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 8395000000 | USD | 20240206 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 8019000000 | USD | 20240206 | Open filing evidence |
Imaging Segment · Interventional Guidance · Operating Segments
Statement Business Segments · Subsegments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=gehc:ImagingSegmentMember;us-gaap:SubsegmentsAxis=gehc:InterventionalGuidanceMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-03-31 | 408000000 | USD | 20230425 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 393000000 | USD | 20230425 | Open filing evidence |
Imaging Segment · Radiology · Operating Segments
Statement Business Segments · Subsegments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=gehc:ImagingSegmentMember;us-gaap:SubsegmentsAxis=gehc:RadiologyMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-03-31 | 2088000000 | USD | 20230425 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 1918000000 | USD | 20230425 | Open filing evidence |
Others
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=gehc:OthersMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-03-31 | 13000000 | USD | 20230425 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 17000000 | USD | 20230425 | Open filing evidence |
Pcs
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=gehc:PcsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-03-31 | 781000000 | USD | 20230425 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 716000000 | USD | 20230425 | Open filing evidence |
PCS Segment · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=gehc:PCSSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 793000000 | USD | 2026-10-28 · 10:26:29.000Z | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 2171000000 | USD | 2026-10-28 · 10:26:29.000Z | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 731000000 | USD | 2026-10-28 · 10:26:29.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 2262000000 | USD | 2026-10-28 · 10:26:29.000Z | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 772000000 | USD | 20240731 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 1519000000 | USD | 20240731 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 3142000000 | USD | 20240206 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 770000000 | USD | 20240731 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 1551000000 | USD | 20240731 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 781000000 | USD | 20230425 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 2916000000 | USD | 20240206 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 716000000 | USD | 20230425 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 2915000000 | USD | 20240206 | Open filing evidence |
PCS Segment · Operating Segments · Life Support Solutions
Statement Business Segments · Consolidation Items · Subsegments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=gehc:PCSSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:SubsegmentsAxis=gehc:LifeSupportSolutionsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-12-31 | 859000000 | USD | 20240206 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 824000000 | USD | 20240206 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 796000000 | USD | 20240206 | Open filing evidence |
PCS Segment · Operating Segments · Monitoring Solutions
Statement Business Segments · Consolidation Items · Subsegments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=gehc:PCSSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:SubsegmentsAxis=gehc:MonitoringSolutionsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-12-31 | 2283000000 | USD | 20240206 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 552000000 | USD | 20230425 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 2092000000 | USD | 20240206 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 521000000 | USD | 20230425 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 2119000000 | USD | 20240206 | Open filing evidence |
PCS Segment · Life Support Solutions · Operating Segments
Statement Business Segments · Subsegments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=gehc:PCSSegmentMember;us-gaap:SubsegmentsAxis=gehc:LifeSupportSolutionsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-03-31 | 229000000 | USD | 20230425 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 195000000 | USD | 20230425 | Open filing evidence |
PCS Segment · Life Support Solutions Subsegment · Operating Segments
Statement Business Segments · Subsegments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=gehc:PCSSegmentMember;us-gaap:SubsegmentsAxis=gehc:LifeSupportSolutionsSubsegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 209000000 | USD | 2026-10-28 · 10:26:29.000Z | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 566000000 | USD | 2026-10-28 · 10:26:29.000Z | Open filing evidence |
| 2026-04-01 – 2026-06-30 | 172000000 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 357000000 | USD | 20260729 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 187000000 | USD | 2026-10-28 · 10:26:29.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 583000000 | USD | 2026-10-28 · 10:26:29.000Z | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 200000000 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 397000000 | USD | 20260729 | Open filing evidence |
PCS Segment · Monitoring Solutions Subsegment · Operating Segments
Statement Business Segments · Subsegments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=gehc:PCSSegmentMember;us-gaap:SubsegmentsAxis=gehc:MonitoringSolutionsSubsegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 584000000 | USD | 2026-10-28 · 10:26:29.000Z | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 1605000000 | USD | 2026-10-28 · 10:26:29.000Z | Open filing evidence |
| 2026-04-01 – 2026-06-30 | 503000000 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 1022000000 | USD | 20260729 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 544000000 | USD | 2026-10-28 · 10:26:29.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 1678000000 | USD | 2026-10-28 · 10:26:29.000Z | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 578000000 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 1135000000 | USD | 20260729 | Open filing evidence |
Pdx
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=gehc:PdxMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-03-31 | 558000000 | USD | 20230425 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 484000000 | USD | 20230425 | Open filing evidence |
P Dx Segment · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=gehc:PDxSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 846000000 | USD | 2026-10-28 · 10:26:29.000Z | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 2458000000 | USD | 2026-10-28 · 10:26:29.000Z | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 749000000 | USD | 2026-10-28 · 10:26:29.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 2110000000 | USD | 2026-10-28 · 10:26:29.000Z | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 639000000 | USD | 20240731 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 1238000000 | USD | 20240731 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 568000000 | USD | 20240731 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 1126000000 | USD | 20240731 | Open filing evidence |
Ultrasound
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=gehc:UltrasoundMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-03-31 | 859000000 | USD | 20230425 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 815000000 | USD | 20230425 | Open filing evidence |
Ultrasound Segment · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=gehc:UltrasoundSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-04-01 – 2024-06-30 | 823000000 | USD | 20240731 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 1647000000 | USD | 20240731 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 3457000000 | USD | 20240206 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 839000000 | USD | 20240731 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 1698000000 | USD | 20240731 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 859000000 | USD | 20230425 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 3422000000 | USD | 20240206 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 815000000 | USD | 20230425 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 3172000000 | USD | 20240206 | Open filing evidence |
Interventional Guidance · Operating Segments · Imaging Segment
Subsegments · Consolidation Items · Statement Business Segments
Source dimensions
us-gaap:SubsegmentsAxis=gehc:InterventionalGuidanceMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=gehc:ImagingSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-07-01 – 2023-09-30 | 398000000 | USD | 20231031 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 1199000000 | USD | 20231031 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 398000000 | USD | 20231031 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 1176000000 | USD | 20231031 | Open filing evidence |
Interventional Guidance · Imaging
Subsegments · Statement Business Segments
Source dimensions
us-gaap:SubsegmentsAxis=gehc:InterventionalGuidanceMember;us-gaap:StatementBusinessSegmentsAxis=gehc:ImagingMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-03-31 | 408000000 | USD | 20230425 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 393000000 | USD | 20230425 | Open filing evidence |
Life Support Solutions · Pcs
Subsegments · Statement Business Segments
Source dimensions
us-gaap:SubsegmentsAxis=gehc:LifeSupportSolutionsMember;us-gaap:StatementBusinessSegmentsAxis=gehc:PcsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-03-31 | 229000000 | USD | 20230425 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 195000000 | USD | 20230425 | Open filing evidence |
Life Support Solutions · PCS Segment · Operating Segments
Subsegments · Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:SubsegmentsAxis=gehc:LifeSupportSolutionsMember;us-gaap:StatementBusinessSegmentsAxis=gehc:PCSSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-04-01 – 2024-06-30 | 235000000 | USD | 20240731 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 454000000 | USD | 20240731 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 207000000 | USD | 20240731 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 436000000 | USD | 20240731 | Open filing evidence |
Monitoring Solutions · Pcs
Subsegments · Statement Business Segments
Source dimensions
us-gaap:SubsegmentsAxis=gehc:MonitoringSolutionsMember;us-gaap:StatementBusinessSegmentsAxis=gehc:PcsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-03-31 | 552000000 | USD | 20230425 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 521000000 | USD | 20230425 | Open filing evidence |
Monitoring Solutions · PCS Segment · Operating Segments
Subsegments · Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:SubsegmentsAxis=gehc:MonitoringSolutionsMember;us-gaap:StatementBusinessSegmentsAxis=gehc:PCSSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-04-01 – 2024-06-30 | 538000000 | USD | 20240731 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 1065000000 | USD | 20240731 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 563000000 | USD | 20240731 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 1115000000 | USD | 20240731 | Open filing evidence |
Radiology · Operating Segments · Imaging Segment
Subsegments · Consolidation Items · Statement Business Segments
Source dimensions
us-gaap:SubsegmentsAxis=gehc:RadiologyMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=gehc:ImagingSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-07-01 – 2023-09-30 | 2237000000 | USD | 20231031 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 6552000000 | USD | 20231031 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 2118000000 | USD | 20231031 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 6100000000 | USD | 20231031 | Open filing evidence |
Radiology · Imaging
Subsegments · Statement Business Segments
Source dimensions
us-gaap:SubsegmentsAxis=gehc:RadiologyMember;us-gaap:StatementBusinessSegmentsAxis=gehc:ImagingMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-03-31 | 2088000000 | USD | 20230425 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 1918000000 | USD | 20230425 | Open filing evidence |